Corneal neovascularization after excimer keratectomy wounds in matrilysin-deficient mice

Investigative Ophthalmology and Visual Science

Volumn 44, Issue 1, 2003, Pages 137-144

  Kure, Tomoko ^a,b   Chang, Jin Hong ^a,b   Kato, Takuji ^a,b   Hernández Quintela, Everardo ^a,b   Ye, Hongqing ^a,b   Lu, Paul Chung Shien ^a,b   Matrisian, Lynn M ^c   Gatinel, Damien ^d   Shapiro, Steven ^e   Gosheh, Faris ^a,b   Azar, Dimitri T ^a,b,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD   (France)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD31 ANTIGEN; COLLAGEN TYPE 4; MATRILYSIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; ELECTRON MICROSCOPY; ENZYME DEFICIENCY; EXCIMER LASER; IMMUNOHISTOCHEMISTRY; KERATECTOMY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING;

ANIMALS; ANTIGENS, CD31; BLOTTING, WESTERN; COLLAGEN TYPE IV; CORNEA; CORNEAL NEOVASCULARIZATION; CORNEAL STROMA; ENDOTHELIAL GROWTH FACTORS; EPITHELIUM, CORNEAL; FEMALE; FIBROBLAST GROWTH FACTOR 2; IMAGE PROCESSING, COMPUTER-ASSISTED; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATECTOMY, PHOTOREFRACTIVE, EXCIMER LASER; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASE 7; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; WOUND HEALING;

EID: 0037251043     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.01-1058     Document Type: Article

References (35)

1. Chang JH, Gabison EE, Kato T, Azar DT. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242-249.
2. O'Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
3. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285.
4. Dawson DW, Volpert OV, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science. 1999;285:245-248.
5. Woessner JF Jr. The matrix metalloproteinase family. In: Parks WC, Mecham RP, eds. Matrix Metalloproteinases. San Diego: Academic Press; 1998:1-14.
6. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274:21491-21494.
7. Liotta LA, Steeg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell. 1991;64:327-336.
8. Saghizadeh M, Brown DJ, Castellon R, et al. Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: a possible mechanism of basement membrane and integrin alterations. Am J Pathol. 2001;158:723-734.
9. Matrisian LM. Matrilysin. In: Parks WC, Mecham RP, eds. Matrix Metalloproteinases. San Diego: Academic Press; 1998:149-184.
10. Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J, Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J. 1988;253:187-192.
11. Abramson SR, Conner GE, Nagase H, Neuhaus I, Woessner JF Jr. Characterization of rat uterine matrilysin and its cDNA: Relationship to human pump-1 and activation of procollagenases. J Biol Chem. 1995;270:16016-16022.
12. Wilson CL, Heppner KJ, Rudolph LA, Matrisian LM. The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell. 1995;6:851-869.
13. Quantin B, Murphy G, Breathnach R. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry. 1989;28:5327-5334.
14. Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, Umeda M. Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res. 1990;50:7758-7764.
15. Murphy G, Cockett MI, Ward RV, Docherty AJ. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan: a quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP). Biochem J. 1991;277:277-279.
16. Mayer U, Mann K, Timpl R, Murphy G. Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. Eur J Biochem. 1993;217:877-884.
17. Sires UI, Griffin GL, Broekelmann TJ, et al. Degradation of entactin by matrix metalloproteinases: susceptibility to matrilysin and identification of cleavage sites. J Biol Chem. 1993;268:2069-2074.
18. Patterson BC, Sang QA. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem. 1997;272:28823-28825.
19. Lu PC, Ye H, Maeda M, Azar DT. Immunolocalization and gene expression of matrilysin during corneal wound healing. Invest Ophthalmol Vis Sci. 1999;40:20-27.
20. Ye HQ, Azar DT. Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci. 1998;39:913-921.
21. Wilson CL, Heppner KJ, Labosky PA, Hogan BLM, Matrisian LM. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA. 1997;94:1402-1407.
22. Moromizato Y, Stechschulte S, Miyamoto K, et al. CD18 and ICAM-1-dependent corneal neovascularization and inflammation after limbal injury. Am J Pathol. 2000;157:1277-1281.
23. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem. 1989;180:487-502.
24. Ishizaki M, Westerhausen-Larson A, Kino J, Hayashi T, Kao WWY. Distribution of collagen IV in human ocular tissues. Invest Ophthalmol Vis Sci. 1993;34:2680-2689.
25. Vecchi A, Garlanda C, Lampugnani MG, et al. Monoclonal antibodies specific for endothelial cells of mouse blood vessels: their application in the identification of adult and embryonic endothelium. Eur J Cell Biol. 1994;63:247-254.
26. DeLisser HM, Newman PJ, Albelda SM. Molecular and functional aspects of PECAM-1/CD31. Immunol Today. 1994;15:490-495.
27. Kenyon BM, Browne F, D'Amato RJ. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res. 1997;64:971-978.
28. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky 1. A heparin-binding angiogenic protein - basic fibroblast growth factor - is stored within basement membrane. Am J Pathol. 1988;130:393-400.
29. Seghezzi G, Patel S, Ren CJ, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J Cell Biol. 1998;141:1659-1673.
30. Di Girolamo N, Coroneo MT, Wakefield D. Active matrilysin (MMP-7) in human pterygia: potential role in angiogenesis. Invest Ophthalmol Vis Sci. 2001;42:1963-1968.
31. Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-β1 release. Biochem J 1997;322:809-814.
32. Lin HC, Chang JH, Jain S, et al. Matrilysin cleavage of corneal collagen type XVIII NC1 domain and generation of a 28 kDa fragment. Invest Ophthalmol Vis Sci. 2001;42:2517-2524.
33. Nishizuka I, Ichikawa Y, Ishikawa T, et al. Matrilysin stimulates DNA synthesis of cultured vascular endothelial cells and induces angiogenesis in vivo. Cancer Lett. 2001;173:175-182.
34. Maeda M, Vanlandingham BD, Ye H, Lu PC, Azar DT. Immunoconfocal localization of gelatinase B expressed by migrating intrastromal epithelial cells after deep annular excimer keratectomy. Curr Eye Res. 1998;17:836-843.
35. Ye HQ, Maeda M, Yu FS, Azar DT. Differential expression of MT1-MMP (MMP-14) and collagenase III (MMP-13) genes in normal and wounded rat corneas. Invest Ophthalmol Vis Sci. 2000;41:2894-2899.